Sha Liu

机构：Dalian University of Technology, Guangxi Normal University, Children's Hospital of Chongqing Medical University, Northwest Normal University, Chongqing Medical University · ORCID：0000-0002-5041-125X

发表论文 32 篇 · 总被引 339 次 · h-index 10

代表论文

• An Fc-Competent Anti-Human TIGIT Blocking Antibody Ociperlimab (BGB-A1217) Elicits Strong Immune Responses and Potent Anti-Tumor Efficacy in Pre-Clinical Models (2022 · Frontiers in Immunology · 被引 55)
• Human ovarian cancer stem-like cells can be efficiently killed by γδ T lymphocytes (2011 · Cancer Immunology Immunotherapy · 被引 54)
• Metagenomic Next-Generation Sequencing vs. Traditional Pathogen Detection in the Diagnosis of Infection After Allogeneic Hematopoietic Stem Cell Transplantation in Children (2022 · Frontiers in Microbiology · 被引 30)
• Sub-Inhibitory Clindamycin and Azithromycin reduce S. aureus Exoprotein Induced Toxicity, Inflammation, Barrier Disruption and Invasion (2019 · Journal of Clinical Medicine · 被引 28)
• DMAG, a novel countermeasure for the treatment of thrombocytopenia (2021 · Molecular Medicine · 被引 27)
• Der p 1 Disrupts the Epithelial Barrier and Induces IL-6 Production in Patients With House Dust Mite Allergic Rhinitis (2021 · Frontiers in Allergy · 被引 25)